FEBS Letters
Volume 582, Issue 6 , Pages 881-885, 19 March 2008

PKC and MEK pathways inhibit caspase-9/-3-mediated cytotoxicity in differentiated cells

Edited by Lukas Huber

  • Giou-Teng Yiang

      Affiliations

    • Institute of Medical Sciences, Tzu-Chi University, Hualien, Taiwan
    • Department of Emergency Medicine, Tzu-Chi General Hospital, Hualien, Taiwan
    • These authors contributed equally to this work.
  • ,
  • Yung-Luen Yu

      Affiliations

    • Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan
    • Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan
    • Department of Biotechnology, Asia University, Taichung, Taiwan
    • These authors contributed equally to this work.
  • ,
  • Sheng-Chuan Hu

      Affiliations

    • Institute of Medical Sciences, Tzu-Chi University, Hualien, Taiwan
    • Department of Emergency Medicine, Tzu-Chi General Hospital, Hualien, Taiwan
    • These authors contributed equally to this work.
  • ,
  • Mark Hung-Chih Chen

      Affiliations

    • Institute of Clinical Nutrition, College of Medicines and Nursings, Hungkuang University, No. 34, Chung-Chie Road, Sha Lu, Taichung 433, Taiwan, ROC
    • Department of Biotechnology, Hungkuang University, Sha Lu, Taichung, Taiwan
  • ,
  • Jaang-Jiun Wang

      Affiliations

    • Division of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, USA
    • This author is co-correspondence author to this study.
  • ,
  • Chyou-Wei Wei

      Affiliations

    • Institute of Clinical Nutrition, College of Medicines and Nursings, Hungkuang University, No. 34, Chung-Chie Road, Sha Lu, Taichung 433, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Fax: +886 4 26338212.

Received 8 January 2008; received in revised form 31 January 2008; accepted 6 February 2008. published online 18 February 2008.

Abstract 

Many studies have indicated that differentiated cells inhibit drug-induced cytotoxicity but undifferentiated cells do not, though the mechanisms are unclear. Currently, HL-60 cells are induced to differentiate into macrophage-like cells with Phorbol-12-myristate-13-acetate (TPA) treatment (TPA-differentiated cells). Our study shows that caspase-9/-3-mediated cytotoxicity can be induced in undifferentiated HL-60 cells but not in TPA-differentiated HL-60 cells. However, caspase-9/-3-mediated cytotoxicity can be induced in TPA-differentiated cells if they are pretreated with a protein kinase C (PKC) or a mitogen activated protein kinase (MEK) inhibitor. Taken together, this study demonstrates that TPA-differentiated HL-60 cells inhibit caspases-9/-3-mediated cytotoxicity through the PKC and MEK signaling pathways.

Keywords: Caspases, PKC, MEK, Differentiation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00123-3

doi:10.1016/j.febslet.2008.02.018

FEBS Letters
Volume 582, Issue 6 , Pages 881-885, 19 March 2008